How Each MPS Subtype Changes the Approach to Therapy
Mucopolysaccharidosis (MPS) represents a group of rare, genetic lysosomal storage conditions caused by specific enzyme deficiencies that impair glycosaminoglycan (GAG) breakdown. GAG accumulation results in progressive organ, bone, and tissue damage. Growing awareness of mucopolysaccharidosis causes is fueling sustained research initiatives and therapeutic development efforts. MPS Disease...
0 Comentários 0 Compartilhamentos 890 Visualizações 0 Anterior
Patrocinado
Patrocinado
Patrocinado
google-site-verification: google037b30823fc02426.html